Skip to main content
Caplight Logo









DepYmed, Inc.

DepYmed, Inc.

Private
Farmingdale, New YorkHealthcare & Life Scienceshttps://www.depymed.com/

Last Round

VC Round

Apr 7, 2021

Total Funding Raised

$2.1M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

DepYmed, Inc. is a pharmaceutical company that develops novel small-molecule therapeutics targeting protein tyrosine phosphatases for the treatment of rare diseases and cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

small-molecule therapeuticsPTP1B inhibitordrug discoveryrare disease treatmentallosteric inhibitorprotein tyrosine phosphatasePTPbiotech startupclinical-stage pharmadrug pipelinebiotechnologyprecision medicineorphan drugRett SyndromeWilson Disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DepYmed, Inc. Comparables

Compare DepYmed, Inc. with similar companies based on industry and business-model similarity.

DepYmed, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kanyr Pharma
81%
Lucy Therapeutics
73%
Unravel Biosciences
72%

DepYmed, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 7, 2021
Series AOct 26, 2016
SeedDec 23, 2015

DepYmed, Inc. Investors

Notable investors and investment history

DepYmed, Inc. investors
InvestorRounds
Accelerate Long IslandSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 69% MoM.

  • Jul 24, 2026

    Monthly visitors grew 229% MoM, from 483 to 1.6K.

DepYmed, Inc. Filings

Explore SEC and related filing metadata, where available.

DepYmed, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DepYmed, Inc.'s valuation, stock price, and market status.

Is DepYmed, Inc. a public or private company?

DepYmed, Inc. is a private company.

What is the current stock price of DepYmed, Inc.?

DepYmed, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is DepYmed, Inc. worth (valuation)?

Valuation information for DepYmed, Inc. is not publicly available.

Can I buy DepYmed, Inc. stock?

DepYmed, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DepYmed, Inc.'s last funding round?

DepYmed, Inc.'s most recent funding round was VC Round on April 7, 2021.

Who are the main investors in DepYmed, Inc.?

Key investors in DepYmed, Inc. include Accelerate Long Island.

Will DepYmed, Inc. IPO soon?

No public IPO plans have been announced for DepYmed, Inc..

How can I track DepYmed, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DepYmed, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFarmingdale, New York
Employee Range1
Year Founded2014
Last FundingApr 7, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?